Reducing Urban Cervical Cancer Disparities
Fox Chase Cancer Center · with Rutgers, The State University of New Jersey, Thomas Jefferson University · NCT06416150
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–90 · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 546
- US sites recruiting
- 3
- Study start
- August 28, 2024
- Record last updated
- October 26, 2024
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study uses a hybrid Type 1 effectiveness-implementation trial to operationalize and assess the efficacy of the Health Enhancement Resource System (HERS) intervention. HERS aims to increase patient follow-up after abnormal test results through text message-based barriers counseling for women and supplemental telephone-based Health Coaching for women who miss their appointment.
Being studied: Stage 1 SOC; Stage 1 HERS; Stage 2 HERS; Stage 2 HERS+HC; Stage 3 SOC; Stage 3 HERS; Stage 3 HERS+HC; Stage 4 HERS; Stage 4 HERS+HC
Conditions: Cervical Cancer; Papilloma Viral Infection
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- 18 to 90 years of age (screening is still recommended for some women over 65-depending on screening and medical history and proceeds until age 90 in the study's clinic recruitment sites),
- referral for colposcopic evaluation at the clinic sites,
- able to communicate with ease in English,
- have a cell phone with texting ability, and
- competent to give consent.
Exclusion Criteria
- are pregnant at the time of recruitment,
- display current evidence or have a history of positive invasive carcinoma of the cervix, or
- require follow-up but not a colposcopy.
Recruiting US locations
Rutgers, The State University of New Jersey
New Brunswick, NJ 08901
Site contact: Shawna Hudson, PhD · (848) 932-0215 · hudsonsh@rutgers.edu
Thomas Jefferson University
Philadelphia, PA 19107
Site contact: Kuang-Yi Wen, PhD · 215-503-4623 · kuang-yi.wen@jefferson.edu
Fox Chase Cancer Center
Philadelphia, PA 19111
Site contact: Erin Tagai, PhD, MPH · 215-728-5621 · erin.tagai@fccc.edu
Study contacts (from the official record)
- Suzanne M Miller, PhD · 215-728-4069 · suzanne.miller@fccc.edu
- Erin K Tagai, PhD, MPH · 215-728-5621 · erin.tagai@fccc.edu
Similar studies in New Jersey
All healthy volunteers studies in New Jersey →- RecruitingHealthy volunteersPhase 1
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
Arcutis Biotherapeutics, Inc.
- Location
- Fair Lawn, NJ + 6 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Clinical Trial of MK-1406 in Healthy Participants (MK-1406-008)
Merck Sharp & Dohme LLC
- Location
- Marlton, NJ + 5 other US sites
- Eligibility basics
- Ages 18–64
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Jersey City, NJ + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
Study of Single Doses of HBS-104 in Acutely Sleep-deprived Healthy Participants
Harmony Biosciences Management, Inc.
- Location
- Eatontown, NJ
- Eligibility basics
- Ages 18–55